First-line molecular therapies in the treatment of metastatic colorectal cancer – a literature-based review of phases II and III trials

Arndt Vogel, Martha M. Kirstein

Open source

DOI
10.1515/iss-2018-0012
Published
2018-05-07
Container
Innovative Surgical Sciences
Publisher
Walter de Gruyter GmbH
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1515/iss-2018-0012,
  title = {First-line molecular therapies in the treatment of metastatic colorectal cancer – a literature-based review of phases II and III trials},
  author = {Arndt Vogel and Martha M. Kirstein},
  year = {2018},
  journal = {Innovative Surgical Sciences},
  doi = {10.1515/iss-2018-0012},
  url = {https://doi.org/10.1515/iss-2018-0012}
}

RIS

TY  - JOUR
TI  - First-line molecular therapies in the treatment of metastatic colorectal cancer – a literature-based review of phases II and III trials
AU  - Arndt Vogel
AU  - Martha M. Kirstein
PY  - 2018
JO  - Innovative Surgical Sciences
DO  - 10.1515/iss-2018-0012
UR  - https://doi.org/10.1515/iss-2018-0012
ER  - 

APA

Vogel, A., & Kirstein, M. M. (2018). First-line molecular therapies in the treatment of metastatic colorectal cancer – a literature-based review of phases II and III trials. Innovative Surgical Sciences. https://doi.org/10.1515/iss-2018-0012

Source records